FindTrial
Sign In

Analysis of risk factors of neoplastic change in gastric hyperplastic polyps

Analysis of risk factors of neoplastic change in gastric hyperplastic polyps

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014493
Enrollment
Unknown
Registered
2018-01-17
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric hyperplastic polyps

Interventions

neoplastic change with gastric hyperplastic polyps:endoscopic resection
non neoplastic change with gastric hyperplastic polyps:endoscopic resection

Sponsors

Beijing Friendship Hospital affiliated Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Pathology confirmed gastric hyperplastic polyp

Exclusion criteria

Exclusion criteria: exclude other malignant tumor and any polyposis syndrome,e.g. Juvenile polyposis, Peutz-Jeghers syndrome, Cronkhite-Canada syndrome, Cowden syndrome, etc.

Design outcomes

Primary

MeasureTime frame
serum anti parietal cell antibody;serum gastrin;—

Secondary

MeasureTime frame
serum vitamin B12;serum iron;anti parietal cell antibody of histology;Ki-67 of histology;gastrin of histology;CgA of histology;Syn of histology;P53 of histology;—

Countries

China

Contacts

Public ContactHu Haiyi

Beijing Friendship Hospital, Capital Medical University

werjw@126.com+86 13811185943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026